MilliporeSigma logo

Is your clinical diagnostics contract manufacturer prepared to weather supply chain challenges?
Supply chain security and transparency is critical to the risk mitigation strategy of companies manufacturing clinical diagnostic assays. Prior to the Covid-19 crisis, complex global supply chains carefully balanced capacity with demand while cost-cutting initiatives pushed towards lower-cost raw material providers typically located in different geographies. Covid-19-driven regional manufacturing shutdowns, surge demands, and logistics disruptions have placed significant pressure on clinical diagnostics supply chains resulting in raw material shortages and delays. For this and future volatile market situations, clinical diagnostics manufacturers should look closely at the supply chain management of potential contract manufacturing partners including some key risk-mitigation strategy considerations.